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Background: Neointimal tissue is typically hypoechoic and concentric and peaks at 6 months after implantation. However, there is little data on 
late in-stent neointima.
Methods: We used baseline and follow-up intravascular ultrasound (IVUS) to assess 27 sirolimus-eluting stented (SES) lesions (25 pts) 3.2±0.9 yrs 
after implantation.
Results: Patient age was 65.8±11.4 yrs and 90% were males, 40.7% were diabetics. SES lesions were in 19 LADs, 5 LCXs, and 3 RCAs. Minimum 
lumen area (MLA) decreased significantly from 6.1±1.31mm2 post-implantation to 3.6±1.5mm2 at follow-up, p=0.003. Overall, 20 SES lesions 
(74%) had in-stent neointimal hyperplasia (NIH); and 9 NIH contained calcification (Figure). Two contained multiple calcifications, 16 were 
accompanied by calcification behind the stent that increased from 57±38° post-implantation to 93±39° at follow-up, p=0.001, and 5 calcifications 
were located proximal to a stent edge in association with progression of calcification behind the stent. One SES lesion had chronic stent recoil at a 
bifurcation location with a decrease in stent area from 5.6 mm2 to 2.5 mm2, 2 SES lesions had partial stent fracture, 2 SES lesions had persistent 
stent malapposition, and 2 SES lesions had late acquired stent malapposition.
Conclusions: calcified in-stent NIH occurs 3 yrs after SES implantation. Calcified NIH supports the concept of in-stent neointimal 
neoatherosclerosis late after SES implantation. 
